Pain and Chemical Dependency Not an “Either – Or” proposition Douglas Gourlay, MD, FRCPC, FASAM Wasser Pain Centre, Toronto ON.

Slides:



Advertisements
Similar presentations
Substance Related Disorders
Advertisements

13 Principles of Effective Addictions Treatment
DSM – 5 Substance-Related and Addictive Disorders
The purpose is not to imply everyone on controlled substances will become addicted!!! Everyone on controlled substances is, however, at increased risk.
Miriam Komaromy, MD Associate Director, Project ECHO Associate Professor, Internal Medicine, UNM 10/2013.
Identifying and Addressing Aberrant Medication Use Behaviors.
What’s New in DSM-5 For Clinicians Working with Mandated Populations State Specialty Court Conference DuAne L. Young The Change Companies®
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
Why Not Use the DSM-IVR for Diagnosing Addiction? Reason #147: Inadequacies of using qualitative indices for a quantitative problem.
PAIN AND ADDICTION Steven Rapaport, MD Attending Physician Comprehensive HIV Center Saint Vincent’s Catholic Medical Center A Local Performance Site of.
Practice Principles and Pharmacology CSD 5970 Counseling the Chemically Dependent.
Alcoholism and Substance Abuse. Focus Alcoholism.
© 2006 McGraw-Hill Higher Education. All rights reserved. Chapter 2 Drug Use As A Social Problem.
Prescription Drug Abuse and Misuse in the Elderly Thomas L. Patterson, Ph.D. Support for this work: NIMH Center Grants P30 MH49693 and MH45131, and by.
Alcoholism and Substance Abuse. Focus Alcoholism.
Substance Abuse Issues in Health Professionals Shannon V Chavez, MD Chair, UCSD Physician Well-Being Committee Director, UCSD Health Professional Program.
Substance Abuse Issues in Chronic Pain Management Steven D. Passik, PhD Director, Oncology Symptom Control and Research Community Cancer Care, Inc. Indianapolis,
1 Prescription Drug Nonmedical Use and Abuse in Older Women Drug abuse in the 21 st century: what lies ahead for the baby boomers? Linda Simoni-Wastila,
SBIRT Module 2: Screening for Substance Use Problems in Primary Care UCSF SBIRT Collaborative Education Project Janice Tsoh, PhD.
Role of Medications in Recovery and the Prevention of Relapse Mark Publicker, MD FASAM Medical Director, Mercy Recovery Center, Westbrook Maine.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
Senior Medical Director, Health Policy
Chapter 4 Screening and Assessment of Alcohol/Drug Problems.
Definition: Drug addiction involves compulsively seeking to use a substance, regardless of the potentially negative social, psychological and physical.
Chemical Addictions — General Overview Abdullahi Mubarak, MD Medical Director of Addiction Services at PEMCO Chief Medical Officer at Consortium Clinical.
Pain Management for Patients in OTPs. Pain Prevalence Study of (2) populations 1 –(390) pts in MMT –(531) pts in short term residential –Prevalence of.
 1.A maladaptive pattern of substance use leading to significant impairment or distress. 2.Presence of two or more of the following symptoms within a.
©2010 McGraw-Hill Higher Education. All rights reserved. Chapter 4 Definitions of Substance Abuse, Dependence, and Addiction.
Aberrant Drug-taking Behaviors in Medically Ill Pain Patients Aberrant Drug-taking Behaviors in Medically Ill Pain Patients Steven D. Passik, PhD Director,
North Carolina TASC Clinical Series Training Module Eight: DSM -IV.
Mood Disorders: Bipolar
Pain and Addiction: Assessment Issues Russell K. Portenoy, MD Chairman, Dept of Pain Medicine and Palliative Care Beth Israel Medical Center New York,
Assessment of Substance Use Disorders
Copyright © 2007 by The McGraw-Hill Companies, Inc. All rights reserved. Chapter 17 Substance-Related Disorders – Focus on Alcoholism.
Concerns About Addiction: Bringing Clarity to Confusion about Addiction Terminology Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 37 Drug Abuse I: Basic Considerations.
OPIOID SUBSTITUTION THERAPY
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
DRUGS OF ABUSE Reynaldo J. Lesaca, M.D. Reynaldo J. Lesaca, M.D.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
Chapter 16 Addictive Disorders. Abuse  Use of a substance that falls outside of medical necessity or social acceptance resulting in adverse effects to.
Substance Use Disorders. A maladaptive pattern of substance use leading to clinically significant social, emotional, or occupational impairment or distress.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
Substance abuse. Definition It’s a mental disorder that shows symptoms and maladaptive behavioral changes with the use of substances that affect the CNS.
Principles of Effective Drug Addiction Treatment Health 10 The Truth About Drugs Ms. Meade.
Chapter 2 Lori L. Phelps California Association for Alcohol/Drug Educators, TRANSDISCIPLINARY FOUNDATION I: UNDERSTANDING ADDICTION Contributors:
Pain Management VS Drug Addiction An Ethical Decision to Treat or Not BY Talisa Burris.
Chronic Pain Management Harald Lausen, DO, MA FCM Clerkship SIU School of Medicine.
Foundations of Addictions Counseling, 3/E David Capuzzi & Mark D. Stauffer Copyright © 2016, 2012, 2008 by Pearson Education, Inc. All Rights Reserved.
HEA 113 Casey Fay, MS. Understand the Addictive Process Discuss reasons why people choose to use or not to use drugs. Identify the types of drug dependence,
SUBSTANCE ABUSE prevention
Kathleen J. Farkas, PhD Case Western Reserve University, Mandel School of Applied Social Sciences Laurie Drabble, PhD San Jose State University, School.
Addiction vs. Physical Dependence Katie Ulrich Clinical Psychologist.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
Terms Related to Substance Abuse
What Our Patients Look Like
WHY A FOCUS ON ADDICTIVE BEHAVIORS?
COMMONLY USED TERMS DR. JOSEPH B. FAMA FPSMS CLINICAL DEPARTMENT HEAD DOH-DRUG TREATMENT AND REHABILITATION CENTER.
Drug Use as a Social Problem
DSM-IV-TR, APA, 2000 Criteria for Substance Dependence:
Alcoholism and unhealthy use
Assessing Opioid Use Disorder, part 1
Diagnosis and Recognition of OUD
Drug Abuse Munir Gharaibeh, MD, PhD, MHPE
Office of Aerospace. Medicine
ADDICTION
Bassett-UMass MAT ECHO.
Acute Pain Management & Addiction
Presentation transcript:

Pain and Chemical Dependency Not an “Either – Or” proposition Douglas Gourlay, MD, FRCPC, FASAM Wasser Pain Centre, Toronto ON

DL Gourlay, MD, FRCPC, FASAM2 The Problem Pain and Addiction CAN coexist Addiction in General Population –Varies 3 – 16% prevalence –Varies with the drug, gender, economic status, race, age… Addiction in the Chronic Pain Population –We really have no idea –We use the same terms, with different meaning Lack of precision in definitions around abuse/dependency/addiction

DL Gourlay, MD, FRCPC, FASAM3 Definitions Addiction: Addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving. (LCPA)

DL Gourlay, MD, FRCPC, FASAM4 Definitions Physical Dependence: Physical dependence is a state of adaptation that often includes tolerance and is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug, and/or administration of an antagonist. (LCPA)

DL Gourlay, MD, FRCPC, FASAM5 Definitions Tolerance: Tolerance is a state of adaptation in which exposure to a drug induces changes that result in a diminution of one or more of the drug's effects over time. Tolerance develops at different rates, in different people, to different effects

DL Gourlay, MD, FRCPC, FASAM6 Definitions Pseudoaddiction: Iatrogenic, maladaptive behavior resulting from inadequate pain control Not to be used “instead of” addiction Unwise to diagnose in patient with history of addictive disorder, even in other substance

DL Gourlay, MD, FRCPC, FASAM7 Addiction * Biology Environment Drug *

DL Gourlay, MD, FRCPC, FASAM8 Diagnosis DSM-IV criteria - dependence –Maladaptive behavior having at least three of the following in a 12 month period Withdrawal Tolerance Use in larger amounts or over longer period than intended Persistent use, or unsuccessful attempts to cut-down or control use XS time spent using or recovering from use Narrowing of focus due to substance use Continued use despite harm

DL Gourlay, MD, FRCPC, FASAM9 Pain and Addiction as Co-morbid Conditions Pain often complicate the Dx of Addiction Pain and Addiction can coexist –Pain plus Alcoholism Cocaine Cannabis –Relatively simple to use current tools to assess addiction i.e. DSM-IV

DL Gourlay, MD, FRCPC, FASAM10 Pain and Opioid Addiction What happens when the ‘drug of choice’ is both the problem AND the solution, depending on point of view? –Addiction Specialist Aberrant behavior is due to opioid abuse/addiction –Pain Specialist Aberrant behavior is due to inadequate treatment of pain (pseudoaddiction)

DL Gourlay, MD, FRCPC, FASAM11 Pain-Addiction Continuum Pain Addiction Patient Patient Patient

DL Gourlay, MD, FRCPC, FASAM12 Boundary Setting 90%+ of patients don’t need strict boundary setting –Most patients have their own internal set For remaining ~10%, strict boundary setting is essential Treatment Agreements, Urine Testing, interval / contingency dispensing

DL Gourlay, MD, FRCPC, FASAM13 Boundaries – Identification and Enforcement Discharge Patient

DL Gourlay, MD, FRCPC, FASAM14 Boundaries – Identification and Enforcement Consultation with Addiction Medicine

DL Gourlay, MD, FRCPC, FASAM15 Aberrant Drug-Related Behaviors Selling prescription drugs Prescription forgery Stealing or “borrowing” drugs from another patient Injecting oral formulations Obtaining prescription drugs from non-medical sources Concurrent abuse of related illicit drugs Multiple unsanctioned dose escalations Repeated episodes of lost prescriptions Aggressive complaining about the need for higher doses Drug hoarding during periods of reduced symptoms Requesting specific drugs Prescriptions from other physicians Unsanctioned dose escalation Unapproved use of the drug Reporting psychic effects not intended by the physician More Predictive Less Predictive Jaffee, 1996

DL Gourlay, MD, FRCPC, FASAM16 Assessing Aberrant Behavior What does it mean? –Aberrant behavior is a late and often unreliable sign of an addictive disorder –When used to trigger UDT, more often used in punitive fashion Aberrant behavior does NOT equal inadequate pain management in all patients

DL Gourlay, MD, FRCPC, FASAM17 Assessment Strategies 1 st address pain complaints –Explore AM pain and role of IR opioids Carefully document medication use –Dosing intervals, what worked, what didn’t –Lost/stolen, early refills, double doctoring, problems with control, withdrawal symptoms Family history of drug/EtOH problems Personal psychiatric history

DL Gourlay, MD, FRCPC, FASAM18 Assessment Strategies Personal Substance Use History –Alcohol, tobacco, street drugs –Time of last use Drug Treatment History Legal Issues Social Physical Examination Lab Tests: Liver, Hepatitis, HIV, CBC, UDS

DL Gourlay, MD, FRCPC, FASAM19 Pain and Chemical Dependency Program Pain and CD Clinic CAMH –Initially at the AMC –Problems with stigma (many “no show’s”) Pain and CD division at the Wasser –Easier for patients to comfortably attend Very few patients fail to attend appointments But difficult to manage dominant SUD pts –“Easier to teach pain docs about addiction”

DL Gourlay, MD, FRCPC, FASAM20 Pain and Chemical Dependency Program Strong bridge between the Wasser Pain Centre and CAMH was needed –Currently fellows and residents from CAMH spend time at the Wasser Clinic on Thursday –Queen Street Lab does UDT for Wasser –Stabilized Pain and CD pts are seen at Wasser But we don’t have a place to manage complex pharmacotherapy problems; we’re not integrated

DL Gourlay, MD, FRCPC, FASAM21 Pain and Chemical Dependency Program 2004, Purdue Canada donated $300,000 over 3 yrs for a Pain and CD division at the Wasser Pain Management Centre –We are now discussing possibilities of having a “Rationalization of Pharmacotherapy Unit” at the Donwood Site –Pts will be assessed and medically stabilized before deciding what services might next be offered

DL Gourlay, MD, FRCPC, FASAM22 Conclusions Pain and Addiction can coexist Successful treatment of either often requires assessment and management of both The Pain and CD Division of the Wasser Pain Centre will do what neither CAMH nor Wasser could do alone